WILLPEDF THERAPY REVERSE CHRONIC DEMYELINATION AND PREVENT AXON LOSS IN A MURINE MODEL TO PROGRESSIVE MULTIPLE SCLEROSIS?
$693,000FY2012Department of the ArmyDOD
University Of California, Davis
Investigators
View source on USAspending →WILLPEDF THERAPY REVERSE CHRONIC DEMYELINATION AND PREVENT AXON LOSS IN A MURINE MODEL TO PROGRESSIVE MULTIPLE SCLEROSIS? · GrantIndex